Stock ICCM ICECURE MEDICAL LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials IceCure Medical Ltd

Equities

ICCM

IL0011224156

Advanced Medical Equipment & Technology

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
1.14 USD -2.56% Intraday chart for IceCure Medical Ltd -4.20% +6.54%
May. 07 Icecure Medical Ltd. Announces That Positive Data from an Independent Study (The "Study") Performed in Japan Was Published in an Article Titled "Percutaneous Ultrasound?Guided Cryoablation for Early?Stage Primary Breast Cancer: A Follow?Up Study in Japan," in the Journal Breast Cancer on April 27, 2024 CI
Apr. 15 IceCure Medical Seeks FDA Nod For ProSense to Treat Early-Stage Breast Cancer MT

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 109.1 70.72 48.84 52.13 - -
Enterprise Value (EV) 1 109.1 70.72 48.84 52.13 52.13 52.13
P/E ratio - -3.37 x -3.34 x -4.07 x -4.56 x -57 x
Yield - - - - - -
Capitalization / Revenue 26.4 x 22.9 x 15.1 x 12.2 x 5.47 x 1.54 x
EV / Revenue 26.4 x 22.9 x 15.1 x 12.2 x 5.47 x 1.54 x
EV / EBITDA - - - - - -
EV / FCF - -4.66 x -3.76 x -3.59 x -4.41 x -4.33 x
FCF Yield - -21.5% -26.6% -27.9% -22.7% -23.1%
Price to Book - - - - - -
Nbr of stocks (in thousands) 35,780 45,623 45,642 45,730 - -
Reference price 2 3.050 1.550 1.070 1.140 1.140 1.140
Announcement Date 4/1/22 3/29/23 4/3/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 4.138 3.085 3.229 4.261 9.534 33.87
EBITDA - - - - - - -
EBIT 1 - -9.724 -16.74 -15.58 -13.86 -12.77 -0.875
Operating Margin - -234.99% -542.59% -482.38% -325.23% -133.93% -2.58%
Earnings before Tax (EBT) 1 - - -16.98 -14.65 -13.62 -12.15 -1.075
Net income 1 -4.528 - -16.98 -14.65 -13.3 -12.03 -1.075
Net margin - - -550.34% -453.76% -312.09% -126.17% -3.17%
EPS 2 - - -0.4600 -0.3200 -0.2800 -0.2500 -0.0200
Free Cash Flow 1 - - -15.18 -13 -14.52 -11.83 -12.04
FCF margin - - -492.16% -402.63% -340.76% -124.07% -35.56%
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 3/25/21 4/1/22 3/29/23 4/3/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 S1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 2.073 0.765 0.634 0.939 0.71 0.937 0.327 1.255 0.8755 1.086 0.9385 1.242
EBITDA - - - - - - - - - - - -
EBIT 1 - -4.281 -4.101 -3.932 -3.957 -4.081 -4.123 -3.415 -3.774 -3.627 -3.719 -3.694
Operating Margin - -559.61% -646.85% -418.74% -557.32% -435.54% -1,260.86% -272.11% -431.13% -334.13% -396.27% -297.34%
Earnings before Tax (EBT) 1 - - -4.058 -3.952 -3.768 -3.889 -4 -2.995 -3.88 -3.8 -3.9 -3.72
Net income 1 3.847 - -4.058 -3.952 -3.768 -3.889 -4 -2.995 -3.774 -3.417 -3.509 -3.484
Net margin 185.58% - -640.06% -420.87% -530.7% -415.05% -1,223.24% -238.65% -431.13% -314.79% -373.89% -280.44%
EPS 2 0.1560 - -0.1100 -0.1060 -0.0800 -0.0880 -0.0870 -0.0600 -0.0800 -0.0700 -0.0700 -0.0700
Dividend per Share - - - - - - - - - - - -
Announcement Date 9/23/21 8/15/22 12/5/22 3/29/23 5/22/23 8/14/23 11/15/23 4/3/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - - -15.2 -13 -14.5 -11.8 -12
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex 1 - - 0.89 0.48 0.25 0.25 0.25
Capex / Sales - - 28.88% 14.87% 5.87% 2.62% 0.74%
Announcement Date 3/25/21 4/1/22 3/29/23 4/3/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for IceCure Medical Ltd

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.14 USD
Average target price
3 USD
Spread / Average Target
+163.16%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
ICECURE MEDICAL LTD Stock IceCure Medical Ltd
+6.54% 52.13M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+11.73% 226B
DANAHER CORPORATION Stock Danaher Corporation
+9.53% 188B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+14.63% 137B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+27.47% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-0.04% 63.19B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.73% 52.26B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+4.86% 51B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+7.72% 43.89B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+7.86% 38.07B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. ICCM Stock
  4. Financials IceCure Medical Ltd
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW